Budget, White Paper Provide Insight Into Trump Administration’s Strategy On Drug Pricing image

Health Affairs, February 12, 2018
Rachel Sachs (Academic Fellow Alumna)


Read the Full Article

From the article:

During his first year in office, President Donald Trump spoke often about the problem of high drug prices but took no action on the subject. President Trump’s new budget proposal and a newly released white paper from the White House Council of Economic Advisors (CEA) aim to change that by laying out a strategy for action moving forward. These documents are, of course, aspirational, but they do provide a window into the administration’s priorities, and they should be evaluated to consider whether the administration has a possibility of achieving its stated goals.

In this post, I review several of the key elements of those proposals, considering their impact on a range of relevant dimensions. I discuss what’s included in the proposals, and, as importantly, what’s left out.

Read more here!

health care finance health care reform health law policy pharmaceuticals public health rachel sachs regulation